Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers

Dawn C. Janysek, Jennifer Kim, Pascal H.G. Duijf, Eloïse Dray

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience